Senseonics Holdings Inc (NYSEMKT:SENS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.

According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “

SENS has been the topic of several other research reports. B. Riley assumed coverage on shares of Senseonics Holdings in a research note on Monday, September 26th. They issued a “buy” rating and a $5.50 price target on the stock. Leerink Swann reiterated an “outperform” rating and issued a $6.00 price target (up previously from $4.50) on shares of Senseonics Holdings in a research note on Thursday, September 22nd. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $6.00 price target on shares of Senseonics Holdings in a research note on Wednesday, August 10th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Senseonics Holdings presently has an average rating of “Buy” and an average target price of $5.25.

Analyst Recommendations for Senseonics Holdings (NYSEMKT:SENS)

Shares of Senseonics Holdings (NYSEMKT:SENS) opened at 3.27 on Wednesday. The company’s market capitalization is $305.38 million. The company has a 50 day moving average price of $3.88 and a 200 day moving average price of $3.62. Senseonics Holdings has a 1-year low of $2.53 and a 1-year high of $4.24.

Senseonics Holdings (NYSEMKT:SENS) last announced its quarterly earnings results on Tuesday, August 9th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.11) by $0.02. Equities analysts predict that Senseonics Holdings will post ($0.49) EPS for the current fiscal year.

Several hedge funds have recently made changes to their positions in SENS. Schwab Charles Investment Management Inc. purchased a new stake in Senseonics Holdings during the second quarter worth $180,000. State Street Corp purchased a new stake in Senseonics Holdings during the second quarter worth $1,185,000. Spark Investment Management LLC raised its stake in Senseonics Holdings by 72.5% in the second quarter. Spark Investment Management LLC now owns 67,800 shares of the company’s stock worth $266,000 after buying an additional 28,500 shares during the period. Abingworth LLP purchased a new stake in Senseonics Holdings during the second quarter worth $2,026,000. Finally, Teachers Advisors Inc. purchased a new stake in Senseonics Holdings during the second quarter worth $175,000.

Senseonics Holdings Company Profile

Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.

Receive News & Stock Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related stocks with our FREE daily email newsletter.